{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-024884","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2021-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.449824+00:00","generated_at":"2026-06-28T22:15:07.268235+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Oncocyte names Gisela Paulsen COO effective Oct 4, 2021; salary $390k, options","bullets":["Gisela Paulsen appointed Chief Operating Officer, effective October 4, 2021.","Annual salary of $390,000 with target bonus of 50% of base salary.","One-time sign-on award of 375,000 stock options vesting over four years.","Previously General Manager of Exact Sciences' Precision Oncology and senior roles at Roche/Genentech.","Severance agreement provides 12 months base salary and accelerated vesting upon certain terminations."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-024884","json":"https://secwatch.observer/filing/0001493152-21-024884.json","markdown":"https://secwatch.observer/filing/0001493152-21-024884.md","text":"https://secwatch.observer/filing/0001493152-21-024884.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315221024884/0001493152-21-024884-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315221024884/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T22:15:07.268235+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3517b96847","claim":"Gisela Paulsen was appointed as Chief Operating Officer at Insight Molecular Diagnostics Inc..","evidence_excerpt":"We have appointed Gisela Paulsen as Chief Operating Officer effective October 4, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315221024884/0001493152-21-024884-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}